Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...

The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...

Merck said on Wednesday that its experimental oral HIV treatment met the main goal of a late-stage trial. The company said ...

Merck & Co. has reported another phase 3 win for islatravir in HIV, advancing its efforts to establish the near-approval ...

Women are disproportionately affected by HIV, making up nearly half of new infections globally and in India. Stigma, gender ...

Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...

But the rollout is now being wielded as a political tool. What that “America First” slogan actually means for global health ...

The candlelighting ceremony at the World AIDS Day commemorative event. (Photo: PIA Samar) An early World AIDS Day observance ...

Cryo-EM revealed HIV-1 integrase’s distinct structures as it shifts between its two roles of DNA integration and RNA-binding.

Learn about the risk of getting HIV from anal sex, vaginal sex, oral sex, and shared needles, plus the most effective ways to ...

The report shows that before the freeze, 87 per cent of Nigeria’s HIV budget depended on US government support.

The United States said Tuesday it has delivered a new treatment to prevent HIV in two African countries, months after ...